BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15835237)

  • 21. Simple quantitative assay for canine steroid-induced alkaline phosphatase.
    Oluju MP; Eckersall PD; Douglas TA
    Vet Rec; 1984 Jul; 115(1):17-8. PubMed ID: 6464340
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma.
    Lautscham EM; Kessler M; Ernst T; Willimzig L; Neiger R
    Vet Rec; 2017 Mar; 180(12):303. PubMed ID: 28100766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?
    MacDonald VS; Thamm DH; Kurzman ID; Turek MM; Vail DM
    J Vet Intern Med; 2005; 19(5):732-6. PubMed ID: 16231719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol.
    Vaughan A; Johnson JL; Williams LE
    J Vet Intern Med; 2007; 21(6):1332-9. PubMed ID: 18196744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000).
    Jagielski D; Lechowski R; Hoffmann-Jagielska M; Winiarczyk S
    J Vet Med A Physiol Pathol Clin Med; 2002 Oct; 49(8):419-24. PubMed ID: 12450190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of canine normal hepatic alkaline phosphatase and variant alkaline phosphatase of serum and liver.
    Hoffmann WE; Dorner JL
    Clin Chim Acta; 1975 Jul; 62(1):137-42. PubMed ID: 238771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Garrett LD; Thamm DH; Chun R; Dudley R; Vail DM
    J Vet Intern Med; 2002; 16(6):704-9. PubMed ID: 12465768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation and heat stability of the corticosteroid-induced and hepatic alkaline phosphatase isoenzymes in canine plasma.
    Teske E; Rothuizen J; de Bruijne JJ; Mol JA
    J Chromatogr; 1986 Nov; 369(2):349-56. PubMed ID: 3805204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidine kinase assay in canine lymphoma.
    Elliott JW; Cripps P; Blackwood L
    Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy followed by half-body radiation therapy for canine lymphoma.
    Williams LE; Johnson JL; Hauck ML; Ruslander DM; Price GS; Thrall DE
    J Vet Intern Med; 2004; 18(5):703-9. PubMed ID: 15515588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol: 38 cases (1996-2003).
    Milner RJ; Peyton J; Cooke K; Fox LE; Gallagher A; Gordon P; Hester J
    J Am Vet Med Assoc; 2005 Oct; 227(7):1118-22. PubMed ID: 16220673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-fetoprotein in canine multicentric lymphoma.
    Lechowski R; Jagielski D; Hoffmann-Jagielska M; Zmudzka M; Winnicka A
    Vet Res Commun; 2002 Jun; 26(4):285-96. PubMed ID: 12184499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options.
    Martineau MM
    Can Vet J; 2002 Sep; 43(9):709-11. PubMed ID: 12240530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).
    Chan CM; Frimberger AE; Moore AS
    Vet Dermatol; 2018 Apr; 29(2):154-e59. PubMed ID: 28983988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of alkaline phosphatase isoenzyme separation by affinity electrophoresis in the dog.
    Kidney BA; Jackson ML
    Can J Vet Res; 1988 Jan; 52(1):106-10. PubMed ID: 3349387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma.
    Moore EL; Vernau W; Rebhun RB; Skorupski KA; Burton JH
    Vet Comp Oncol; 2018 Mar; 16(1):E45-E51. PubMed ID: 28660709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.